EUVIMEDEUVIMED entdecken
Open Access

Prevalence, Phenotypes, and Comorbidities of Polycystic Ovary Syndrome Among Indian Women

Mohd Ashraf Ganie, Subhankar Chowdhury, Neena Malhotra, Rakesh Sahay, Prasanta Kumar Bhattacharya, Sarita Agrawal, P K Jabbar, Vanita Suri, Roya Rozati, Vishnubhatla Sreenivas, Mohammad Salem Baba, Imtiyaz Ahmad Wani und 6 weitere

JAMA Network Open · 23.10.2024 · 7 (10) · e2440583

DOI: 10.1001/jamanetworkopen.2024.40583 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JAMA Network Open, online erschienen am 23.10.2024. Verfasst von Mohd Ashraf Ganie und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, Sher-i-Kashmir Institute of Medical Sciences, Srinagar, India. Hauptthemen laut MEDLINE: Polycystic Ovary Syndrome, Phenotype, Comorbidity. Die Arbeit wurde bisher 63-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Importance The prevalence of polycystic ovary syndrome (PCOS) varies across the globe. Indian studies on PCOS are limited by poor design, small sizes, regional representations, and varying methods.

Objectives

To estimate the nationwide prevalence of PCOS in India, examine the phenotypic spectrum, and assess the magnitude of comorbidities associated with PCOS. Design, Setting, and Participants This cross-sectional study recruited 9824 women aged 18 to 40 years from November 1, 2018, to July 31, 2022, across 5 zones of the country. A prevalidated questionnaire dichotomized women into screen-positive and screen-negative groups. Relevant clinical, hormonal, and sonographic assessments categorized women as either women with criteria-based PCOS (ie, National Institutes of Health [NIH] 1990 criteria, Rotterdam 2003 criteria, or Androgen Excess and Polycystic Ovary Syndrome Society [AE-PCOS] criteria), women with partial phenotypes (hyperandrogenism, oligomenorrhea, or polycystic morphology labeled as pre-PCOS), or healthy women, in addition to quantitating various comorbidities. Main Outcomes and Measures The prevalence and phenotypes of PCOS among women of reproductive age and the burden of comorbidities associated with PCOS.

Results

A total of 8993 women (mean [SD] age, 29.5 [6.2] years) were enrolled in this study; 196 women were already diagnosed with PCOS, 2251 were categorized as screen positive, and 6546 were categorized as screen negative. The mean (SD) age of screen-positive women (28.1 [6.4] years) was lower than that of screen-negative women (29.7 [6.1] years) ( P < .001), and the mean (SD) age at menarche was higher in the former group (13.2 [1.3] vs 13.1 [1.2] years; P < .001). The national prevalence of PCOS was 7.2% (95% CI, 4.8%-10.8%) by NIH 1990 criteria, 19.6% (95% CI, 12.7%-29.2%) by Rotterdam 2003 criteria, and 13.6% (95% CI, 8.4%-21.6%) by AE-PCOS criteria. Overall, PCOS phenotypes C (501 [40.8%]) and D (301 [24.6%]) were the most common, and 492 women (pre-PCOS subgroup) had oligomenorrhea (n = 75), hyperandrogenism (n = 257), or polycystic ovarian morphology (n = 160) only. Among women with PCOS (n = 1224), obesity was present in 529 (43.2%), dyslipidemia in 1126 (91.9%), nonalcoholic fatty liver disease in 403 (32.9%), metabolic syndrome in 305 (24.9%), impaired glucose tolerance in 111 (9.1%), diabetes in 41 (3.3%), and hypertension in 101 (8.3%). The pre-PCOS subgroup (n = 492) displayed similar metabolic aberrations (dyslipidemia: 390 [79.3%]; metabolic syndrome: 78 [15.9%]; nonalcoholic fatty liver disease: 163 [33.1%]; impaired glucose tolerance: 62 [12.6%]; diabetes: 7 [1.4%]; and hypertension: 26 [5.3%]). Conclusions and Relevance In this cross-sectional study of reproductive-age women recruited across India, the prevalence of PCOS was high, with phenotype C being predominant. Most of these women had metabolic abnormalities. These findings are crucial for developing preventive and therapeutic strategies, potentially integrating PCOS management into national health programs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Polycystic Ovary SyndromePhenotypeComorbidityHumansFemaleIndiaAdultPrevalenceCross-Sectional StudiesYoung AdultAdolescentHyperandrogenism

Autor:innen und Institutionen

  • Department of Endocrinology, Sher-i-Kashmir Institute of Medical Sciences, Srinagar, India.
  • Department of Clinical Research, Sher-i-Kashmir Institute of Medical Sciences, Srinagar, India.
  • Department of Endocrinology Metabolism, Institute of Postgraduate Medical Education Research, Kolkata, India.
  • Department of Obstetrics and Gynaecology, All India Institute of Medical Sciences, New Delhi, India.
  • Department of Endocrinology, Osmania Medical College, Hyderabad, India.
  • Department of General Medicine, North-Eastern Indira Gandhi Regional Institute of Health and Medical Sciences, Shillong, India.

Zitieren

APA

Ganie, M. A., Chowdhury, S., Malhotra, N., Sahay, R., Bhattacharya, P. K., Agrawal, S., Jabbar, P. K., Suri, V., Rozati, R., Sreenivas, V., Baba, M. S., Wani, I. A., Rashid, H., Nair, A., Shukla, A., Arora, T., Kulkarni, B., & PCOS Study Group (2024). Prevalence, Phenotypes, and Comorbidities of Polycystic Ovary Syndrome Among Indian Women. JAMA Network Open, 7(10), e2440583. https://doi.org/10.1001/jamanetworkopen.2024.40583

Vancouver

Ganie MA, Chowdhury S, Malhotra N, Sahay R, Bhattacharya PK, Agrawal S, et al. Prevalence, Phenotypes, and Comorbidities of Polycystic Ovary Syndrome Among Indian Women. JAMA Network Open. 2024;7(10):e2440583. doi:10.1001/jamanetworkopen.2024.40583

BibTeX
@article{Ganie2024,
  author = {Ganie, Mohd Ashraf and Chowdhury, Subhankar and Malhotra, Neena and Sahay, Rakesh and Bhattacharya, Prasanta Kumar and Agrawal, Sarita and Jabbar, P K and Suri, Vanita and Rozati, Roya and Sreenivas, Vishnubhatla and Baba, Mohammad Salem and Wani, Imtiyaz Ahmad and Rashid, Haroon and Nair, Abhilash and Shukla, Amlin and Arora, Taruna and Kulkarni, Bharati and PCOS Study Group, PCOS Study Group},
  title = {Prevalence, Phenotypes, and Comorbidities of Polycystic Ovary Syndrome Among Indian Women},
  journal = {JAMA Network Open},
  year = {2024},
  volume = {7},
  number = {10},
  pages = {e2440583},
  doi = {10.1001/jamanetworkopen.2024.40583}
}
Kostenlos starten →